Stay updated with breaking news from Development Rd Dr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Department of Science and Technology (DOST) is seeking more participants for its ongoing randomized controlled clinical trial on the efficacy and safety of tawa-tawa (Euphorbia hirta) extract as an adjunctive coronavirus disease (COVID-19) treatment for mild to moderate cases. Tawa-tawa (Man
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research a
The Department of Science and Technology (DOST) has invested P8.4 million to determine the safety and efficacy of virgin coconut oil (VCO) as adjunctive therapy for coronavirus disease (COVID-19) patients, and to evaluate its beneficial effects for probable COVID-19 patients who are quarantined in a
There is no definite schedule yet as to when the World Health Organization’s (WHO) Solidarity Vaccine Trial (SVT) will start, the Department of Science and Technology (DOST) said. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&D) Dr. Rowena Cristina L. Guev
The second and third phases of the clinical study on the safety and efficacy of the plant-based anti-dengue drug will start in September this year, and "will be completed within a year", the Department of Science and Technology (DOST) said on Friday, Aug. 20. (MANILA BULLETIN FILE PHOTO) DOST U